Senior insider sale
Chief Technology Officer at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$82.2K
2.88K shares
What this filing means
HARMON CYRUS plans to sell 2.88K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $82.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/22/2025ACC: 0001959173-25-007887
DirectorOfficer· Chief Technology Officer
Since Nov 2020
2.88K
Shares to sell
$82.2K
Approx. market value
2.88K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Founders Shares
Compensation
3/20/2007
2.88KTotal acquired2.88K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/20/2007 | Founders Shares Compensation | 2.88K | — |
| Total | 2.88K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.88K
Market value
$82.2K
12/22/2025
Total
Units
2.88K
Value
$82.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/22/2025 | 2.88K | $82.2K | NASDAQ | Planned |
| Total | 2.88K | $82.2K | ||